parkinsons
Table of Contents
Parkinson's disease
see also:
Introduction
- slowly progressive degenerative disorder of the CNS mainly starting in those aged over 60yrs (when it occurs before age 50yrs it is called early-onset PD)
- motor impairments (“parkinsonism”) arise from the death of cells in the substantia nigra (in the basal ganglia within the midbrain) leading to a dopamine deficit.
- 1st detailed description was made by English doctor James Parkinson in 1817
Epidemiology
- affects 1% of those aged over 60yrs
- male:female ratio is 3:2
Risk factors
- coffee, tea drinking and tobacco smoking appear to offer reduced risk
- genetic factors
- pesticide / herbicide exposure eg. paraquat seems to double risk in those who live near where paraquat is sprayed such as grain fields
- PH head injuries
- low serum urate levels have been correlated with increased risk
Clinical features
- early cognitive features
- 19% have cognitive impairments at time of diagnosis (most patients present with motor symptoms first)
- those who develop dementia before or at the same time of PD motor symptoms are usually given the diagnosis of dementia with Lewy bodies
- executive functioning impairments
- multitasking, switching tasks, and solving problems
- trouble recalling information but their long-term memory function generally remains intact
- attention difficulties
- trouble maintaining focus, especially as the complexity of a situation increases
- slowed thinking or processing, also known as bradyphrenia
- problem-solving, conversations
- impaired word finding, naming objects, generating words, comprehension, and verbal concepts
- visual-spatial impairments
- difficulties in perceiving, processing, discriminating, and acting on visual information around the person
- motor impairments
- reduced arm movements when walking
- reduced eye blinking
- monotone voice
- flattened facial expression range
- Parkinsonian tremor
- difficulty initiating movements resulting in increased falls
- autonomic dysfunction
- orthostatic hypotension and falls risk
- constipation
- impaired stomach emptying (gastric dysmotility)
- further, later, cognitive impairments may include
- psychosis - occurs in 50% and may herald onset of dementia
- apathy
- anhedonia
- depression (esp. if early-onset PD, women, PH depression, severe motor symptoms)
Diagnosis
- primarily clinical
DDx
other conditions that affect the substantia nigra
- toxins which can cause parkinsonism include:
- manganese
- carbon disulfide
- trichloroethylene (TCE)
- reversible parkinsonism may be caused by medications such as:
- phenothiazines (chlorpromazine, promazine, etc.)
- butyrophenones (haloperidol, benperidol, etc.)
- metoclopramide
- tetrabenazine
- vascular parkinsonism
- the presence of Parkinson's disease symptoms combined with findings of vascular events (such as a cerebral stroke).
- multiple system atrophy (MSA)
- MSA includes disorders that historically had been referred to as Shy-Drager syndrome, olivopontocerebellar atrophy, and striatonigral degeneration
- progressive supranuclear palsy
- corticobasal degeneration
- dementia with Lewy bodies
- brain tumours
- Alzheimer's disease
- concussions, repetitive brain trauma
- encephalitis
- Huntington's disease
Prognosis
- average life expectancy following diagnosis is between 7 and 15 years
Mx
- initial treatment options include:
- levodopa (L-DOPA)
- MAO-B inhibitors
- dopamine agonists
- over time these become less effective and these may also cause:
- involuntary movement disorder
- dopamine dysregulation syndrome including impulse-control disorders, gambling, compulsive sexual behaviours, etc
- “punding” - complicated, repetitive, aimless, stereotyped behaviors occur for many hours
- surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective
parkinsons.txt · Last modified: 2024/10/27 21:47 by gary1